Retatrutide

Retatrutide (LY3437943) serves as a cutting-edge 39-amino acid synthetic peptide, functioning as a potent triple hormone receptor agonist for the GLP-1, GIP, and Glucagon receptors. By simultaneously targeting these three critical metabolic pathways, the compound provides a sophisticated high-precision model for exploring synergistic energy expenditure, lipid metabolism, and multi-receptor mediated weight regulation within advanced endocrine research.

Rigorous analytical verification via HPLC and LC-MS ensures a superior purity profile exceeding 99.5%, guaranteeing the elimination of truncated sequences or trifluoroacetic acid (TFA) residues that could interfere with sensitive bioassays. Our manufacturing protocol utilizes specialized vacuum-lyophilization technology to preserve the peptide's conformational stability, resulting in a highly uniform crystalline cake optimized for rapid laboratory reconstitution and consistent molar concentration in longitudinal studies.